Search

everythinglearnresearchcommunity

for

Search:↓

TNFα, IFNγ, and Substance P significantly affect prolactin levels in human skin, suggesting new treatments for skin and hair conditions.

Tofacitinib successfully treated hair loss in a Crohn's disease patient who previously used adalimumab.

Metformin, usually used for diabetes, can also help treat hair loss from alopecia areata due to its ability to reduce inflammation and stimulate new hair growth.

Dermal Papilla cells are a promising tool for evaluating hair growth treatments.

The review suggests that other immune cells besides CD8+ T cells may contribute to alopecia areata and that targeting regulatory cell defects could improve treatment.

SOCS3 treatment can prevent hair loss by stopping harmful immune responses.

More research is needed to understand and manage rheumatoid arthritis better.

Tofacitinib regrew hair in a man with total hair loss but raised cytokine levels, needing more research on possible side effects.

Alopecia areata can be reversed by JAK inhibitors, promoting hair regrowth.

Ebastine may help regrow hair in alopecia areata patients.

Prednisone has risks for lupus patients, isotretinoin is safe for mental health, transplant patients risk skin cancer, and various treatments are effective for specific skin conditions.

CRH in the skin acts like the body's stress response system, affecting cell behavior and immune activity.

17β-estradiol can reduce inflammation in the skin.

Stem cell treatment from umbilical cords reduces symptoms of atopic dermatitis and may help hair growth.

Metabolic issues may trigger lymphocytic cicatricial alopecia, and treatments targeting these issues could help.

ILC1-like cells may contribute to hair loss in alopecia areata.

ILC1-like cells may contribute to hair loss in alopecia areata and could be new treatment targets.

MMP-2 and MMP-9 help hair grow, while their inhibitors peak when hair growth slows.

Alopecia areata is caused by immune system attacks on hair follicles, often triggered by viral infections.

Baricitinib is effective and safe for treating severe alopecia areata, promoting significant hair regrowth.

Blocking certain immune signals can reduce skin damage from radiation therapy.

Human hair follicle stem cells can help treat bone loss in osteoporosis.

Recent findings suggest that genetic factors, immune system issues, and skin cell defects might contribute to the development of hidradenitis suppurativa.

Pine bark extract helps mice grow hair by reducing inflammation and boosting growth factors.

New Australian advertising rules improved stem cell marketing practices but further regulation is needed for consumer safety.

Ritlecitinib helps reduce inflammation and promote hair regrowth in alopecia areata, especially in patchy-type cases.

Tofacitinib was effective for severe, treatment-resistant hair loss without side effects.

Dysplastic nevi have unique gene expressions, making them distinct from common melanocytic nevi.

NK cells play a role in skin diseases like eczema and psoriasis.

As skin cells mature, vitamin D receptor levels decrease while retinoid X receptor α levels increase.